Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall
Tracks: Adult ID, Pediatric ID
Presentations:
Pertussis Vaccine Effectiveness and Waning Immunity in Alberta, Canada: 2004-2015
Christopher A. Bell, MPH;
Steven J. Drews, PhD;
Kimberley A. Simmonds, PhD;
Lawrence W. Svenson, PhD;
Natasha S Crowcroft, MD, PhD;
Kevin Schwartz, MD, MSc;
Jeffrey C. Kwong, MD;
Salah Mahmud, Ph.D.;
Margaret L. Russell, MD PhD
Meningococcal ACWY (MenACWY) Vaccination of Adolescents in the US: How Compliant Are We with the Advisory Committee on Immunization Practices (ACIP) Recommendations?
Wendy Cheng, MPH, MPhil;
Rose Chang, MSPH, MS, ScD;
Patricia Novy, PhD;
Cristi O'Connor, MHS;
Mei Sheng Duh, MPH, ScD;
Cosmina Hogea, PhD
Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents
Tanya Myers, PhD, MSc;
Eric Weintraub, MPH;
Michael McNeil, MD, MPH;
Lakshmi Sukumaran, MD, MPH;
Jonathan Duffy, MD;
Roger Baxter, MD, FIDSA;
Nicola P. Klein, MD, PhD;
Matthew F. Daley, MD;
James Donahue, DVM, PhD;
Hung Fu Tseng, PhD, MPH;
Stephanie Irving, MHS;
Michael L. Jackson, PhD, MPH;
Saad Omer, MBBS, MPH, PhD, FIDSA
Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014-2017
Jorge Arana, MD, MPH;
John Su, MD, MPH;
Paige Lewis, MSPH;
Maria Cano, MD, MPH;
Lauri E. Markowitz, MD;
Tom Shimabukuro, MD, MPH, MBA
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
